FR – Neoadyuvancia en melanoma

Un estudio identifica haplogrupos heredables asociados a mayor riesgo de resistencia a los regímenes terapéuticos basados en el agente anti-PD-1 nivolumab.

Introduction The incidence of cutaneous melanoma is rising fast, and its prevalence has doubled in the past 3 decades. Detailed local epidemiological information is essential for informing community-based prevention strategies and optimizing hospital resources. Material […]